Dynavax Technologies Corp. (DVAX) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1153350,
    "name": "Dynavax Technologies Corp.",
    "stock_name": "Dynavax Technologies Corp.",
    "full_name": "Dynavax Technologies Corp.",
    "name_url": "stocks-analysis/dynavax-technologies-corp",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "10.96",
    "chg": 0.08,
    "chgp": "0.74%",
    "dir": 1,
    "prev_price": "10.88",
    "mcapval": "1,137.49",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US2681582019",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "3.0 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dynavax-technologies-corp-1153350-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Dynavax Technologies Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dynavax-technologies-corp-technical-trend-shifts-from-mildly-bearish-to-bearish-amid-mixed-performance-3619789",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/DynavaxTechnolo_technicaldot_3619789.png",
        "date": "2025-10-14 15:48:34",
        "description": "Dynavax Technologies Corp. has recently revised its evaluation amid fluctuating market conditions. The stock, currently priced at $10.01, has shown significant volatility over the past year. Performance metrics indicate mixed trends, with varying returns compared to the S&P 500, highlighting the complexities of its market position."
      },
      {
        "title": "Is Dynavax Technologies Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-dynavax-technologies-corp-technically-bullish-or-bearish-3614567",
        "imagepath": "",
        "date": "2025-10-13 11:37:02",
        "description": "As of 10 October 2025, the technical trend for Dynavax Technologies Corp. has changed from mildly bearish to bearish. The current technical stance is bearish, with key indicators supporting this view including bearish MACD readings on both weekly and monthly time frames, a bearish daily moving average, and bearish Bollinger Bands on the weekly chart. The KST shows a mildly bullish signal weekly, but this is overshadowed by the overall bearish trend. \n\nIn terms of performance, the stock has underperformed the S&P 500 year-to-date, down 22.00% compared to the S&P's gain of 11.41%, and has also lagged over the past year with a return of -3.11% against the S&P's 13.36%...."
      },
      {
        "title": "Is Dynavax Technologies Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-dynavax-technologies-corp-technically-bullish-or-bearish-3612898",
        "imagepath": "",
        "date": "2025-10-12 11:25:23",
        "description": "As of 10 October 2025, the technical trend for Dynavax Technologies Corp. has changed from mildly bearish to bearish. The current stance is bearish with weak strength indicated by the MACD being bearish on both weekly and monthly time frames, and daily moving averages also showing a bearish trend. Bollinger Bands confirm a bearish outlook on the weekly and a mildly bearish stance on the monthly. The KST and Dow Theory show mixed signals, with weekly indicators being mildly bullish but monthly indicators leaning bearish. \n\nIn terms of performance, the stock has underperformed the S&P 500 year-to-date, down 22.00% compared to the S&P's gain of 11.41%, and over the last three years, it has declined by 10.03% while the S&P has surged 81.39%...."
      },
      {
        "title": "Is Dynavax Technologies Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-dynavax-technologies-corp-technically-bullish-or-bearish-3546196",
        "imagepath": "",
        "date": "2025-09-20 19:26:50",
        "description": "As of 4 September 2025, the technical trend for Dynavax Technologies Corp. has changed from mildly bearish to bearish. The current stance is bearish with a weak strength indicated by the MACD being bearish on both weekly and monthly time frames, and moving averages also showing a bearish signal on the daily. The Bollinger Bands reflect a bearish condition on the monthly and mildly bearish on the weekly. The KST is mildly bullish weekly but bearish monthly, while the Dow Theory indicates a mildly bearish stance in both time frames. \n\nIn terms of performance, Dynavax has underperformed against the S&P 500 across multiple periods, with a year-to-date return of -23.65% compared to the S&P's 12.22%, and a one-year return of -13.02% versus the S&P's 17.14%...."
      },
      {
        "title": "Is Dynavax Technologies Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-dynavax-technologies-corp-overvalued-or-undervalued-3542808",
        "imagepath": "",
        "date": "2025-09-20 18:02:47",
        "description": "As of 6 May 2025, the valuation grade for Dynavax Technologies Corp. has moved from fair to risky, indicating a shift towards a more cautious outlook. The company appears to be overvalued, particularly given its high P/E ratio of 54, which significantly exceeds the industry average, and a PEG ratio of 0.58 that suggests potential growth is not adequately reflected in the current price. Additionally, the EV to EBITDA ratio is notably negative at -832.88, further highlighting valuation concerns.\n\nIn comparison to its peers, Dynavax's P/E ratio is higher than that of Blueprint Medicines Corp. at -53.75 and Axsome Therapeutics, Inc. at -29.91, both of which are also classified as risky. The company's recent stock performance has lagged behind the S&P 500, with a year-to-date return of -23.65% compared to the index's 12.22%, reinforcing the notion of overvaluation amidst a challenging market environment...."
      },
      {
        "title": "Dynavax Technologies Hits 52-Week Low at $9.21 Amid Market Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dynavax-technologies-hits-52-week-low-at-921-amid-market-struggles-3519566",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/DynavaxTechnolo_priceRelatedfactors_3519566.png",
        "date": "2025-09-16 11:20:38",
        "description": "Dynavax Technologies Corp. has reached a new 52-week low of USD 9.21, reflecting a 22.45% decline over the past year. The company, with a market capitalization of USD 1,137 million, has a P/E ratio of 54.00 and a return on equity of 5.94%, indicating a premium valuation."
      }
    ],
    "total": 11,
    "sid": "1153350",
    "stock_news_url": "https://www.marketsmojo.com/news/dynavax-technologies-corp-1153350"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Dynavax Technologies Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics

2025-10-14 15:48:34

Dynavax Technologies Corp. has recently revised its evaluation amid fluctuating market conditions. The stock, currently priced at $10.01, has shown significant volatility over the past year. Performance metrics indicate mixed trends, with varying returns compared to the S&P 500, highlighting the complexities of its market position.

Is Dynavax Technologies Corp. technically bullish or bearish?

2025-10-13 11:37:02

As of 10 October 2025, the technical trend for Dynavax Technologies Corp. has changed from mildly bearish to bearish. The current technical stance is bearish, with key indicators supporting this view including bearish MACD readings on both weekly and monthly time frames, a bearish daily moving average, and bearish Bollinger Bands on the weekly chart. The KST shows a mildly bullish signal weekly, but this is overshadowed by the overall bearish trend. In terms of performance, the stock has underperformed the S&P 500 year-to-date, down 22.00% compared to the S&P's gain of 11.41%, and has also lagged over the past year with a return of -3.11% against the S&P's 13.36%....

Is Dynavax Technologies Corp. technically bullish or bearish?

2025-10-12 11:25:23

As of 10 October 2025, the technical trend for Dynavax Technologies Corp. has changed from mildly bearish to bearish. The current stance is bearish with weak strength indicated by the MACD being bearish on both weekly and monthly time frames, and daily moving averages also showing a bearish trend. Bollinger Bands confirm a bearish outlook on the weekly and a mildly bearish stance on the monthly. The KST and Dow Theory show mixed signals, with weekly indicators being mildly bullish but monthly indicators leaning bearish. In terms of performance, the stock has underperformed the S&P 500 year-to-date, down 22.00% compared to the S&P's gain of 11.41%, and over the last three years, it has declined by 10.03% while the S&P has surged 81.39%....

Is Dynavax Technologies Corp. technically bullish or bearish?

2025-09-20 19:26:50

As of 4 September 2025, the technical trend for Dynavax Technologies Corp. has changed from mildly bearish to bearish. The current stance is bearish with a weak strength indicated by the MACD being bearish on both weekly and monthly time frames, and moving averages also showing a bearish signal on the daily. The Bollinger Bands reflect a bearish condition on the monthly and mildly bearish on the weekly. The KST is mildly bullish weekly but bearish monthly, while the Dow Theory indicates a mildly bearish stance in both time frames. In terms of performance, Dynavax has underperformed against the S&P 500 across multiple periods, with a year-to-date return of -23.65% compared to the S&P's 12.22%, and a one-year return of -13.02% versus the S&P's 17.14%....

Is Dynavax Technologies Corp. overvalued or undervalued?

2025-09-20 18:02:47

As of 6 May 2025, the valuation grade for Dynavax Technologies Corp. has moved from fair to risky, indicating a shift towards a more cautious outlook. The company appears to be overvalued, particularly given its high P/E ratio of 54, which significantly exceeds the industry average, and a PEG ratio of 0.58 that suggests potential growth is not adequately reflected in the current price. Additionally, the EV to EBITDA ratio is notably negative at -832.88, further highlighting valuation concerns. In comparison to its peers, Dynavax's P/E ratio is higher than that of Blueprint Medicines Corp. at -53.75 and Axsome Therapeutics, Inc. at -29.91, both of which are also classified as risky. The company's recent stock performance has lagged behind the S&P 500, with a year-to-date return of -23.65% compared to the index's 12.22%, reinforcing the notion of overvaluation amidst a challenging market environment....

Dynavax Technologies Hits 52-Week Low at $9.21 Amid Market Struggles

2025-09-16 11:20:38

Dynavax Technologies Corp. has reached a new 52-week low of USD 9.21, reflecting a 22.45% decline over the past year. The company, with a market capitalization of USD 1,137 million, has a P/E ratio of 54.00 and a return on equity of 5.94%, indicating a premium valuation.

View All News